% | $
Quotes you view appear here for quick access.

Pernix Therapeutics Holdings, Inc. Message Board

  • zero.risk13 zero.risk13 Nov 12, 2013 11:47 AM Flag

    Switch to GTHP: Market Cap $40M: Cervical Cancer Scan Approved in Asia, EU, Canada.....

    Awaiting FDA approval.

    The biophotonics scan will replace 60 million annual PAP smears.
    It's more accurate, noninvasive and provides instantaneous test results.


0.440.00(+0.09%)May 31 4:00 PMEDT